252 related articles for article (PubMed ID: 16315010)
1. Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.
Esteban J; Ortiz A; Jiménez MS
Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):856-7. PubMed ID: 16315010
[No Abstract] [Full Text] [Related]
2. E-test: an alternative method for susceptibility testing of Mycobacterium tuberculosis.
Akcali S; Cicek C; Surucuoglu S; Ozbakkaloglu B
Med Princ Pract; 2005; 14(4):264-7. PubMed ID: 15961938
[TBL] [Abstract][Full Text] [Related]
3. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Dickinson JM; Aber VR; Mitchison DA
Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study.
Kontos F; Maniati M; Costopoulos C; Gitti Z; Nicolaou S; Petinaki E; Anagnostou S; Tselentis I; Maniatis AN
J Microbiol Methods; 2004 Feb; 56(2):291-4. PubMed ID: 14744458
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial resistance in tuberculosis].
Gutiérrez-Aroca JB; Ruiz P; Casal M
Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
[TBL] [Abstract][Full Text] [Related]
7. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
Eltringham IJ; Wilson SM; Drobniewski FA
J Clin Microbiol; 1999 Nov; 37(11):3528-32. PubMed ID: 10523547
[TBL] [Abstract][Full Text] [Related]
9. [Culture and susceptibility testing of mycobacteria with VersaTREK].
Gravet A; Souillard N; Habermacher J; Moser A; Lohmann C; Schmitt F; Delarbre JM
Pathol Biol (Paris); 2011 Feb; 59(1):32-8. PubMed ID: 20850229
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
Joloba ML; Bajaksouzian S; Jacobs MR
J Clin Microbiol; 2000 Oct; 38(10):3834-6. PubMed ID: 11015413
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems.
Tortoli E; Mattei R; Savarino A; Bartolini L; Beer J
Diagn Microbiol Infect Dis; 2000 Oct; 38(2):83-6. PubMed ID: 11035238
[TBL] [Abstract][Full Text] [Related]
12. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
[TBL] [Abstract][Full Text] [Related]
13. [Response to the short-course chemotherapy in patients presenting initial resistance].
Mitchison DA
Bull Int Union Tuberc; 1985; 60(1-2):41-3. PubMed ID: 2416375
[No Abstract] [Full Text] [Related]
14. In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
Uttley AH; Collins CH
Tubercle; 1988 Sep; 69(3):193-5. PubMed ID: 3151140
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of the action of drugs in the short-course chemotherapy].
Mitchison DA
Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374
[No Abstract] [Full Text] [Related]
16. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
[TBL] [Abstract][Full Text] [Related]
17. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Iacobino A; Giannoni F; Pardini M; Piccaro G; Fattorini L
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010861
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.
Bergmann JS; Woods GL
J Clin Microbiol; 1998 Oct; 36(10):2940-3. PubMed ID: 9738047
[TBL] [Abstract][Full Text] [Related]
19. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
Kobayashi I; Abe C; Mitarai S
Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
[TBL] [Abstract][Full Text] [Related]
20. The effect of radiation on microbiologic characteristics of M tuberculosis.
Zack MB; Stottmeier K; Berg G; Kazemi H
Chest; 1974 Sep; 66(3):240-3. PubMed ID: 4213816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
